Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01850290 · ClinicalTrials.gov registry record
Imaging Dopamine Function and Its Impact on Outcome After Traumatic Brain Injury (TBI)
A clinical trial of Traumatic Brain Injury, sponsored by Baylor Research Institute.
- Completed
- Registry status
- 18
- Enrollment target
- 1
- Study location
NCT01850290 is a study of Traumatic Brain Injury that has completed, run by Baylor Research Institute. The registered enrollment target is 18 participants, below the 277-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01850290, a study of Traumatic Brain Injury, has completed, sponsored by Baylor Research Institute.
- COMPLETED
- Registry status
- 18 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will examine resting dopamine function as well as dopamine response in the brain as it interacts with medicines normally prescribed to subacute Traumatic Brain Injury (TBI) patients.
Conditions Studied
Study Locations (1)
Texas
- Baylor Research Institute - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2013-05 |
| Est. Completion | 2016-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01850290
The ClinicalTrials.gov registry entry for NCT01850290 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 277-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (94% lower). The listed sponsor is Baylor Research Institute, which has 180 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Traumatic Brain Injury appearing as the primary indexed condition, and to 0 interventions.
NCT01850290 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT01850290 about?
NCT01850290 is a clinical study titled "Imaging Dopamine Function and Its Impact on Outcome After Traumatic Brain Injury (TBI)". This study will examine resting dopamine function as well as dopamine response in the brain as it interacts with medicines normally prescribed to subacute Traumatic Brain Injury (TBI) patients.
What is the current status of trial NCT01850290?
This trial is currently completed. The enrollment target is 18 participants. The study started on 2013-05. Estimated completion is 2016-03.
What conditions does trial NCT01850290 study?
This clinical trial studies the following conditions: Traumatic Brain Injury.
Who is sponsoring clinical trial NCT01850290?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01850290 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Traumatic Brain Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
tPBM in Older Adults With Traumatic Brain Injury
RECRUITING · NA
-
Hyperpolarized 13C-pyruvate Metabolic MRI With Traumatic Brain Injury
RECRUITING · Phase 1
-
Carbon Dioxide Administration and Brain Waste Clearance
RECRUITING · NA
-
TMS-fNIRS Personalized Dosing
RECRUITING · NA
-
Cortical Spreading Depolarization After Severe Traumatic Brain Injury
RECRUITING
-
A Study to Evaluate the SENSE Device's Ability to Detect TBI
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.